PATENT CLAIM ANALYSIS

Application Number: 16206814
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["514", "312000"]

Abstract:
The present specification discloses pharmaceutical compositions, methods of preparing such pharmaceutical compositions, and methods and uses of treating a chronic inflammation and/or an inflammatory disease in an individual using such pharmaceutical compositions.

Claim (Index 19):
The solid solution pharmaceutical composition according to  claim 18 , wherein the one or more propionic acid derived NSAID is an ibuprofen, wherein the one or more pharmaceutically-acceptable glycerolipids includes one or more glycerolipids comprising a mixture of saturated C 10 -C 18  triglycerides having a melting point range of about 41\u00b0 C. to 45\u00b0 C., and wherein the one or more monoglycerides includes glycerol monolinoleate.

Metadata:
- Claim Count in Document: 68.0
- Percentile: 98.0
- Lexical Diversity: 1.4
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['16166272', '15794214', '15794197', '15794178', '15195623']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8054565091639637
- 35 USC 102 Novelty (BERT): 0.6187772944437224
- Combined Prediction Score: 0.7867885876919396
- Mean Citation Score: 530.5367660000002
- Max Citation Score: 538.4187
- Similarity Product: 536.229911908096

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test